MYGN CIK: 899923

Myriad Genetics, Inc.

  • United States
  • Healthcare
  • MedTech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
18.6
FY22:
−106
FY23:
−111
FY24:
−8.70
FY25:
1.80
Change from FY21 to FY25
millions USD
FY21:
274
FY22:
−77.5
FY23:
31.9
FY24:
−11.9
FY25:
−27.4
Change from FY21 to FY25
millions USD
FY21:
−151
FY22:
−8.00
FY23:
153
FY24:
−7.40
FY25:
64.2
millions USD
FY21:
142
FY22:
−192
FY23:
74.5
FY24:
−29.0
FY25:
39.4
(positive)
Change from FY21 to FY25
millions USD
FY21:
0.60
FY22:
−152
FY23:
−174
FY24:
−27.7
FY25:
−13.8

All amounts in millions USD Data source:SEC EDGAR